Chargement en cours...
Selective review and commentary on emerging pharmacotherapies for opioid addiction
Pharmacotherapies for opioid addiction under active development in the US include lofexidine (primarily for managing withdrawal symptoms) and Probuphine®, a distinctive mode of delivering buprenorphine for six months, thus relieving patients, clinicians, and regulatory personnel from most concerns a...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3846315/ https://ncbi.nlm.nih.gov/pubmed/24474855 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/SAR.S22782 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|